Loading...

NovaBridge Biosciences

NBP•NASDAQ
Healthcare
Biotechnology
$2.60
$0.06(2.36%)
U.S. Market opens in 16h 41m

NovaBridge Biosciences (NBP) Stock Overview

Explore NovaBridge Biosciences’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap299.7M
P/E Ratio-36.18
EPS (TTM)$-0.48
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$1.67
3 Months$0.00
1 Year Target$0.00

NBP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NovaBridge Biosciences (NBP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.98, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -36.18 and a market capitalization of 299.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.36%
5-Day Change
9.24%
1-Month Change
-8.13%
3-Month Change
-28.96%
6-Month Change
-57.59%
Year-to-Date (YTD) Change
-34.67%
1-Year Change
186.60%
3-Year Change
-27.98%
5-Year Change
-95.45%
All-Time (Max) Change
-79.20%

Contact Information

https://www.i-mabbiopharma.com
240 745 6330
2440 Research Boulevard, Rockville, MD, 20850

Company Facts

32 Employees
IPO DateJan 17, 2020
CountryUS
Actively Trading

Frequently Asked Questions